Donald P. Land
Research Subjects
Research Interests
Donald P. Land has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Vergara
Department of Ecology and Evolutionary Biology, University of Colorado Boulder
2 shared publications - Kymron Decesare
Steep Hill Labs Inc., Berkeley, California, USA
2 shared publications - Nolan C. Kane
Department of Ecology and Evolutionary Biology, University of Colorado, Boulder, Colorado, USA
2 shared publications - Anthony Torres
Steep Hill Labs Inc
1 shared publication Bailey Rhan
Leafly.com, Seattle, Washington, USA
1 shared publicationBrian J. Pearson
Mid-Florida Research and Education Center, University of Florida, Apopka, Florida, USA
1 shared publication
Latest Publications
- 1 November 2016
- Published by Taylor & Francis in Critical Reviews in Plant Sciences
- Vol. 35 (5-6) , 425-426
Current and Future Needs and Applications for Cannabis
- 1 November 2016
- Published by Taylor & Francis in Critical Reviews in Plant Sciences
- Vol. 35 (5-6) , 425-426
Current and Future Needs and Applications for Cannabis
- Open Access
Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets
As the most widely used illicit drug, the basis of the fastest growing major industry in the US, and as a source of numerous under-studied psychoactive compounds, understanding the psychological and physiological effects of Cannabis is essential. The National Institute on Drug Abuse (NIDA) is designated as the sole legal producer of Cannabis for use in US research studies. We sought to compare the chemical profiles of Cannabis varieties that are available to consumers in states that have state-legalized use versus what is available to researchers interested in studying the plant and its effects. Our results demonstrate that the federally produced Cannabis has significantly less variety and lower concentrations of cannabinoids. Current research, which has focused on material that is far less diverse and less potent than that used by the public, limits our understanding of the plant’s chemical, biological, psychological, medical, and pharmacological properties. Investigation is urgently needed on the diverse forms of Cannabis used by the public in state-legal markets.
Open AccessCompromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets
As the most widely used illicit drug, the basis of the fastest growing major industry in the US, and as a source of numerous under-studied psychoactive compounds, understanding the psychological and physiological effects of Cannabis is essential. The National Institute on Drug Abuse (NIDA) is designated as the sole legal producer of Cannabis for use in US research studies. We sought to compare the chemical profiles of Cannabis varieties that are available to consumers in states that have state-legalized use versus what is available to researchers interested in studying the plant and its effects. Our results demonstrate that the federally produced Cannabis has significantly less variety and lower concentrations of cannabinoids. Current research, which has focused on material that is far less diverse and less potent than that used by the public, limits our understanding of the plant’s chemical, biological, psychological, medical, and pharmacological properties. Investigation is urgently needed on the diverse forms of Cannabis used by the public in state-legal markets.